🇺🇸 FDA
Pipeline program

Simponi 50 mg solution for injection in pre-filled syringe., Simponi 45 mg/0.45 mL solution for injection in pre-filled pen., Simponi 100 mg solution for injection in pre-filled syringe.

CNTO148UCO3003

Phase 3 small_molecule active

Quick answer

Simponi 50 mg solution for injection in pre-filled syringe., Simponi 45 mg/0.45 mL solution for injection in pre-filled pen., Simponi 100 mg solution for injection in pre-filled syringe. for Ulcerative Colitis is a Phase 3 program (small_molecule) at Janssen-Cilag International NV with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International NV
Indication
Ulcerative Colitis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials